We are excited to introduce our new pneumococcal study, focused on evaluating the safety and effectiveness of a potential new vaccine to prevent infections caused by Streptococcus pneumoniae. These infections, including pneumonia and meningitis, can pose serious health risks. By joining this study, participants will help advance research that could improve prevention and care for pneumococcal disease worldwide.